Literature DB >> 25528443

MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.

Yongtao Gao1, Te Liu2, Yongyi Huang3.   

Abstract

We aimed to ascertain the role of microRNAs (miRNAs) in regulating human endometrial cancer stem cells (HuECSCs). The expression level of miRNA-134 (miR-134), a member of the DLK1-DIO3 genomic imprinted miRNA cluster, differed significantly between HuECSCs and human endometrial cancer cells (HuECCs). miR-134 inhibited HuECSCs proliferation and migration by targeting protein O-glucosyltransferase 1 (POGLUT1) expression. Exogenous miR-134 overexpression downregulated POGLUT1 and Notch pathway proteins in HuECSCs in vitro. miR-134 overexpression affected the G2/M phase of HuECSCs and suppressed the growth of xenograft tumours formed. Thus, endogenous miR-134 regulation in HuECSCs may suppress tumourigenesis in human endometrial carcinoma.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DLK1-DIO3 genomic imprinted microRNA cluster; Human endometrial cancer stem cell; MicroRNA-134; Migration; Notch pathway; Proliferation; Protein O-glucosyltransferase 1

Mesh:

Substances:

Year:  2014        PMID: 25528443     DOI: 10.1016/j.febslet.2014.12.002

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  Noncoding RNAs and pancreatic cancer.

Authors:  Juan-Fei Peng; Yan-Yan Zhuang; Feng-Ting Huang; Shi-Neng Zhang
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

2.  Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 3.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

4.  MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1.

Authors:  Jipeng Li; Ying Chen; Mingwei Jin; Jianhua Wang; Shanfeng Li; Zhe Chen; Wanjun Yu
Journal:  Oncol Lett       Date:  2017-01-05       Impact factor: 2.967

5.  The oncogenic role of SOX8 in endometrial carcinoma.

Authors:  Wenyan Tian; Zhanghuan Li; Lu Bai; Lingli Chen; Ye Yan; Huihui Li; Yanyan Han; Fei Teng; Chao Gao; Fengxia Xue; Yingmei Wang
Journal:  Cancer Biol Ther       Date:  2020-11-16       Impact factor: 4.742

6.  miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.

Authors:  Yi Han; Yubo Liu; Xirao Fu; Qi Zhang; Huang Huang; Cheng Zhang; Wenli Li; Jianing Zhang
Journal:  J Physiol Biochem       Date:  2018-07-13       Impact factor: 4.158

7.  microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).

Authors:  Yuan Li; Yong Fu; Yu Gao; Haiying Li; Lei Ma; Chunmen Shu; Na Li; Chong Ma
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

8.  Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells.

Authors:  Kan Fang; Peifeng Liu; Suyan Dong; Yanjie Guo; Xinxin Cui; Xiaoying Zhu; Xuan Li; Lianghan Jiang; Te Liu; Yuncheng Wu
Journal:  Int J Oncol       Date:  2016-06-08       Impact factor: 5.650

9.  miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.

Authors:  Sherien M El-Daly; Mohammed L Abba; Nitin Patil; Heike Allgayer
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

10.  Protein O-Glucosyltransferase 1 (POGLUT1) Promotes Mouse Gastrulation through Modification of the Apical Polarity Protein CRUMBS2.

Authors:  Nitya Ramkumar; Beth M Harvey; Jeffrey D Lee; Heather L Alcorn; Nancy F Silva-Gagliardi; C Jane McGlade; Timothy H Bestor; Jan Wijnholds; Robert S Haltiwanger; Kathryn V Anderson
Journal:  PLoS Genet       Date:  2015-10-23       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.